Lansoprazole Capsule, Delayed Release
Product Images NDC 60687-111

9 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 60687-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp11121

Ahp11121
Two Lansoprazole delayed-release capsules shown against a gray background with measurement markings. Each capsule is half pink and half green. The pink half of the top capsule is imprinted with "R D Y" and the green half is imprinted with "LAN". The bottom capsule shows the same color scheme without visible markings. The capsules are solid, smooth, and elliptical in shape.*
FDA Label Image

Ahp12301

Ahp12301
Capsules of Lansoprazole, delayed release, with one half pink and the other half black. One capsule is imprinted with "RDY" on the pink side and "399" on the black side in white ink. The capsules are oral dosage form. Labeler is American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of lansoprazole, showing the molecular arrangement including a benzimidazole ring, sulfinyl linkage, and substituted pyridine ring with trifluoromethoxy and methyl groups.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients,' comparing severity over approximately 60 days from treatment start. The chart shows three lines representing placebo, lansoprazole 15 mg, and lansoprazole 30 mg, indicating changes in mean heartburn severity scored from 0 (none) to 3 (severe).*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph showing the mean severity of night heartburn over approximately 60 days from the start of treatment. The graph compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, illustrating trends in symptom severity among evaluable patients over time.*
FDA Label Image

15 mg Lansoprazole Tablets Carton (15 mg Lansoprazole Tablets Carton)

15 mg Lansoprazole Tablets Carton (15 mg Lansoprazole Tablets Carton)
Lansoprazole 15 mg delayed-release capsules, USP, oral dosage form, in a 30-capsule package (3 bottles of 10 capsules each). The label specifies storage instructions, pharmacist dispensing guidance, and includes an NDC barcode. Distributed by American Health Packaging, Columbus, Ohio.*
FDA Label Image

15 mg Lansoprazole Dr Capsule Blister (15 mg Lansoprazole Dr Capsule Blister)

15 mg Lansoprazole Dr Capsule Blister (15 mg Lansoprazole Dr Capsule Blister)
Label panel for Lansoprazole Delayed-Release Capsule, USP 15 mg by American Health Packaging. The label includes drug name, strength (15 mg), dosage form (delayed-release capsule), lot number 123456, and expiration date 01/16. The layout repeats the information multiple times with both upright and upside-down text, including a barcode on each panel.*
FDA Label Image

30 mg Lansoprazole Tablets Carton (30 mg Lansoprazole Tablets Carton)

30 mg Lansoprazole Tablets Carton (30 mg Lansoprazole Tablets Carton)
Packaging label for Lansoprazole delayed-release capsules, USP, 30 mg strength, containing 100 capsules (10 x 10) indicated for prescription use only. The label includes the NDC number 60687-123-01 and notes the labeler as American Health Packaging. It provides storage instructions, pharmacist dispensing guidance, and a barcode along with a QR code for medication guide and prescribing information.*
FDA Label Image

30 mg Lansoprazole Dr Capsule Blister (30 mg Lansoprazole Dr Capsule Blister)

30 mg Lansoprazole Dr Capsule Blister (30 mg Lansoprazole Dr Capsule Blister)
Packaging label for Lansoprazole delayed-release capsules, USP 30 mg by American Health Packaging. The label includes the drug name, strength (30 mg), dosage form (capsule, delayed release), lot number (123456), and expiry date (01/16). Several identical labels are shown for individual capsule packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.